ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE;DAIICHI SANKYO COMPANY, LIMITED
发明人:
YAMANO, YOSHIHISA,UEDA, NATSUMI,ARAKI, KAZUSHI
申请号：
CA3050221
公开号：
CA3050221A1
申请日:
2018.01.18
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention provides a pharmaceutical composition which can be used for the treatment of HTLV-1-associated myelopathy and contains an inhibitor selected from the group consisting of an EZH1 inhibitor, an EZH2 inhibitor and an EZH1/2 double inhibitor as an active ingredient. The present invention provides a pharmaceutical composition which can be used for the treatment of HTLV-1-associated myelopathy and contains a 1,3-benzodioxole derivative or a pharmaceutically acceptable salt thereof.
